ArticleNanomedicine : nanotechnology, biology, and medicine2015

A tumor-targeting p53 nanodelivery system limits chemoresistance to temozolomide prolonging survival in a mouse model of glioblastoma multiforme.

Sang-Soo Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.